UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group

Journal for immunotherapy of cancer, 2017-11, Vol.5 (1), p.95-28, Article 95

2017

Volltextzugriff (PDF)

Recent skin self-examination and doctor visits in relation to melanoma risk and tumour depth

British journal of dermatology (1951), 2013-03, Vol.168 (3), p.571-576

2013

Volltextzugriff (PDF)

Autoimmune diseases and immune-checkpoint inhibitors for cancer therapy: review of the literature and personalized risk-based prevention strategy

Annals of oncology, 2020-06, Vol.31 (6), p.724-744

2020

Volltextzugriff (PDF)

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684

Journal of clinical oncology, 1996-01, Vol.14 (1), p.7-17

1996

Volltextzugriff (PDF)

High-Dose Interferon Alfa-2b Significantly Prolongs Relapse-Free and Overall Survival Compared With the GM2-KLH/QS-21 Vaccine in Patients With Resected Stage IIB-III Melanoma: Results of Intergroup Trial E1694/S9512/C509801

Journal of clinical oncology, 2001-05, Vol.19 (9), p.2370-2380

2001

Volltextzugriff (PDF)

High- and Low-Dose Interferon Alfa-2b in High-Risk Melanoma: First Analysis of Intergroup Trial E1690/S9111/C9190

Journal of clinical oncology, 2000-06, Vol.18 (12), p.2444-2458

2000

Volltextzugriff (PDF)

Tolerability of immune checkpoint inhibition cancer therapy in a cardiac transplant patient

Annals of oncology, 2016-12, Vol.27 (12), p.2304-2305

2016

Volltextzugriff (PDF)

Phase III Multicenter Randomized Trial of the Dartmouth Regimen Versus Dacarbazine in Patients With Metastatic Melanoma

Journal of clinical oncology, 1999-09, Vol.17 (9), p.2745-2751

1999

Volltextzugriff (PDF)

Adjuvant Therapy of Stage III and IV Malignant Melanoma Using Granulocyte-Macrophage Colony-Stimulating Factor

Journal of clinical oncology, 2000-04, Vol.18 (8), p.1614-1621

2000

Volltextzugriff (PDF)

Homozygous Deletions within Human Chromosome Band 9p21 in Melanoma

Proceedings of the National Academy of Sciences - PNAS, 1992-11, Vol.89 (21), p.10557-10561

1992

Volltextzugriff (PDF)

A flow cytometric method to estimate the precursor frequencies of cells proliferating in response to specific antigens

Journal of immunological methods, 1999-11, Vol.230 (1), p.99-112

1999

Volltextzugriff (PDF)

Maximum androgen blockade in advanced prostate cancer: A meta-analysis of published randomized controlled trials using nonsteroidal antiandrogens

Urology (Ridgewood, N.J.), 1997, Vol.49 (1), p.71-78

1997

Volltextzugriff (PDF)

Early recovery of aggressive cytotoxic cells and improved immune resurgence with post-transplant immunotherapy for multiple myeloma

Bone marrow transplantation (Basingstoke), 2007-06, Vol.39 (11), p.695-703

2007

Volltextzugriff (PDF)

Maximum androgen-blockade with medical or surgical castration in advanced prostate cancer: A meta-analysis of nine published randomized controlled trials and 4128 patients using flutamide

Prostate cancer and prostatic diseases, 1999-01, Vol.2 (1), p.4-8

1999

Volltextzugriff (PDF)

Tissue-shrinkage correction factor in the calculation of prostate cancer volume

The American journal of surgical pathology, 1996-12, Vol.20 (12), p.1501-1506

1996

Volltextzugriff (PDF)

IN VIVO DESCRIPTION OF DENDRITIC CELLS IN HUMAN RENAL CELL CARCINOMA

The Journal of urology, 1999-08, Vol.162 (2), p.567-573

1999

Volltextzugriff (PDF)

Interferons in the treatment of human cancer

Journal of clinical oncology, 1984-04, Vol.2 (4), p.336-352

1984

Volltextzugriff (PDF)

Expression of Fas(APO-1/CD95) in tumor-infiltrating and peripheral blood lymphocytes in patients with renal cell carcinoma

Cancer research (Chicago, Ill.), 1998-05, Vol.58 (10), p.2078-2080

1998

Volltextzugriff (PDF)

Taxanes Synergize with the Bispecific Antibody MDXH447 to Enhance Antibody-Dependent Cell-Mediated Cytotoxicity

Journal of chemotherapy (Florence), 2003-10, Vol.15 (5), p.472-479

2003

Volltextzugriff (PDF)

Melanoma. Screening and education

Clinics in plastic surgery, 2000-07, Vol.27 (3), p.317-322

Ernstoff, M S

2000

Volltextzugriff (PDF)

Temozolomide and whole brain irradiation in melanoma metastatic to the brain: a phase II trial of the Cytokine Working Group

Journal of cancer research and clinical oncology, 2002-04, Vol.128 (4), p.214-218

2002

Volltextzugriff (PDF)

Interferon Alfa-2b Adjuvant Therapy of High-Risk Resected Cutaneous Melanoma: The Eastern Cooperative Oncology Group Trial EST 1684

Journal of clinical oncology, 2023-01, Vol.41 (3), p.425-435

2023

Volltextzugriff (PDF)

T-cell receptor ζ-chain expression on tumor-infiltrating lymphocytes from renal cell carcinoma

Cancer research (Chicago, Ill.), 1997-08, Vol.57 (16), p.3517-3519

1997

Volltextzugriff (PDF)

Immunohistochemical Localization of Metallothionein in Transitional Cell Carcinoma of the Bladder

The Journal of urology, 1991-12, Vol.146 (6), p.1518-1520

1991

Volltextzugriff (PDF)

Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls

International journal of epidemiology, 2009-06, Vol.38 (3), p.814-830

2009

Volltextzugriff (PDF)

1 – 25 von 468

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(441)
Mit Volltextzugriff
(372)

Publikationsform

Sprache

Englisch
(466)
Französisch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(288)
Science & Technology
(283)
Life Sciences & Biomedicine
(281)
Female
(183)
Oncology
(166)
Biological And Medical Sciences
(165)
Middle Aged
(160)
Medical Sciences
(158)
Aged
(143)
Adult
(130)
Male
(116)
Tumors
(81)
Risk Factors
(64)
Case-Control Studies
(54)
Gynecology. Andrology. Obstetrics
(50)
Immunotherapy
(48)
Pharmacology. Drug Treatments
(46)
Public, Environmental & Occupational Health
(46)
Melanoma
(45)
Mammary Gland Diseases
(40)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group

Recent skin self-examination and doctor visits in relation to melanoma risk and tumour depth

Autoimmune diseases and immune-checkpoint inhibitors for cancer therapy: review of the literature and personalized risk-based prevention strategy

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684

High-Dose Interferon Alfa-2b Significantly Prolongs Relapse-Free and Overall Survival Compared With the GM2-KLH/QS-21 Vaccine in Patients With Resected Stage IIB-III Melanoma: Results of Intergroup Trial E1694/S9512/C509801

High- and Low-Dose Interferon Alfa-2b in High-Risk Melanoma: First Analysis of Intergroup Trial E1690/S9111/C9190

Tolerability of immune checkpoint inhibition cancer therapy in a cardiac transplant patient

Phase III Multicenter Randomized Trial of the Dartmouth Regimen Versus Dacarbazine in Patients With Metastatic Melanoma

Adjuvant Therapy of Stage III and IV Malignant Melanoma Using Granulocyte-Macrophage Colony-Stimulating Factor

Homozygous Deletions within Human Chromosome Band 9p21 in Melanoma

A flow cytometric method to estimate the precursor frequencies of cells proliferating in response to specific antigens

Maximum androgen blockade in advanced prostate cancer: A meta-analysis of published randomized controlled trials using nonsteroidal antiandrogens

Early recovery of aggressive cytotoxic cells and improved immune resurgence with post-transplant immunotherapy for multiple myeloma

Maximum androgen-blockade with medical or surgical castration in advanced prostate cancer: A meta-analysis of nine published randomized controlled trials and 4128 patients using flutamide

Tissue-shrinkage correction factor in the calculation of prostate cancer volume

IN VIVO DESCRIPTION OF DENDRITIC CELLS IN HUMAN RENAL CELL CARCINOMA

Interferons in the treatment of human cancer

Expression of Fas(APO-1/CD95) in tumor-infiltrating and peripheral blood lymphocytes in patients with renal cell carcinoma

Taxanes Synergize with the Bispecific Antibody MDXH447 to Enhance Antibody-Dependent Cell-Mediated Cytotoxicity

Melanoma. Screening and education

Temozolomide and whole brain irradiation in melanoma metastatic to the brain: a phase II trial of the Cytokine Working Group

Interferon Alfa-2b Adjuvant Therapy of High-Risk Resected Cutaneous Melanoma: The Eastern Cooperative Oncology Group Trial EST 1684

T-cell receptor ζ-chain expression on tumor-infiltrating lymphocytes from renal cell carcinoma

Immunohistochemical Localization of Metallothionein in Transitional Cell Carcinoma of the Bladder

Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls

Suchergebnisse filtern